Peter Altman - 03 Sep 2024 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: President and CEO, Director
Signature: /s/ David McClung, by power of attorney
Issuer symbol: BCDA
Transactions as of: 03 Sep 2024
Transactions value $: $124,998
Form type: 4
Filing time: 05 Sep 2024, 12:40:52 UTC
Previous filing: 02 Jul 2024
Next filing: 16 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$125K	+41.7K	+104.83%	$3.00	81.4K	03 Sep 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Warrant (right to buy)	Award		+41.7K			41.7K	03 Sep 2024	Common Stock	41.7K	$3.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.